Atlas Trials

A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC.

Clinical trial NCT06134973 · UNKNOWN

Trial details

NCT number
NCT06134973
Sponsor
Tianjin Third Central Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2023-09-01
Primary completion
2025-06-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.